Synthesis and hypoglycemic activity of some substituted flavonyl thiazolidinedione derivatives—fifth communication: flavonyl benzyl substituted 2,4-thiazolidinediones
- 31 January 2003
- journal article
- research article
- Published by Elsevier BV in Il Farmaco
- Vol. 58 (1), 79-83
- https://doi.org/10.1016/s0014-827x(02)01241-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Diabetes, Exercise, and AtherosclerosisDiabetes Care, 1992
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992
- Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular DiseaseDiabetes Care, 1991
- Studies on Antidiabetic Agents. X. Synthesis and Biological Activities of Pioglitazone and Related Compounds.CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
- Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agentsJournal of Medicinal Chemistry, 1991
- Studies on hindered phenols and analogs. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidationJournal of Medicinal Chemistry, 1989
- Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes, 1988
- Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty ratsDiabetes, 1988
- Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agentDiabetes, 1983
- Studies on antidiabetic agents. II. Synthesis of 5-(4-(1-methylcyclohexylmethoxy)-benzyl)thiazolidine-2,4-dione (ADD-3878) and its derivatives.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982